Table 2:
Risk factor | Type I | Type II | Endometrioid | Serous | Carcinosarcoma | Clear cell |
---|---|---|---|---|---|---|
Obesity | +++ | ++ | +++ | ++ | ++ | ++ |
Diabetes | + | + | + | + | NA | NA |
Metabolic syndrome | + | + | + | + | + | + |
Nulliparity | ++ | + | ++ | + | + | NA |
Infertility | + | + | ||||
Early age at menarche | + | ++ | + | ++ | NA | NA |
Late age at natural menopause | -- | NA | ||||
Breastfeeding | - | NA | ||||
Combination oral contraceptives | -- | -- | --- | NA | NA | -- |
Intrauterine device use | - | NA | ||||
Menopausal estrogen plus progestins | -- | NA | ||||
High cumulative doses of tamoxifen | ++ | ++ | ||||
Cigarette smoking | -- | -- | -- | -- | NA | |
Moderate-to-vigorous physical activity | -- | -- | ||||
Family history | + | ++ |
Red indicates that the factor is positively associated with risk of the particular subtype.
indicates a strong association (RR/OR ≥5.0),
a moderate association (RR/OR, 2–5), and
, a modest association (RR/OR <2).
Green indicates that the factor is negatively associated with risk of the particular subtype.
, a strong association (RR/OR ≤0.6);
, a moderate association (RR/OR, 0.6–0.8); and
, a modest association (RR/OR ≥0.8).
Blue (N/A) indicates the factor is not associated with risk of the particular subtype